Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Colorectal Neoplasms 5Neoplasms 4Malnutrition 3Lung Neoplasms 3Diarrhea 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Mucositis 2Inflammation 2Enteritis 2Chalazion 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Radiation Injuries 1Psychological Well-Being 1Psoriasis Vulgaris 1Polycystic Ovary Syndrome 1Periampullary Carcinoma Nos 1Pelvic Neoplasms 1Pelvic Inflammatory Disease 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

poly ICLC 1Vinorelbine 1Therapeutics 1Probiotics 1Poly I-C 1Pemetrexed 1Paclitaxel 1Monatide (IMS 3015) 1Docetaxel 1Cosmetics 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinogenesis × Probiotics × Clear all
NCT05544396 2024-11-14

Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.

National Cheng-Kung University Hospital

Phase NA Active not recruiting
100 enrolled

Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡